ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer

Publisher: John Wiley & Sons Inc

E-ISSN: 2045-7634|4|5|759-769

ISSN: 2045-7634

Source: Cancer Medicine, Vol.4, Iss.5, 2015-05, pp. : 759-769

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract